Here's another idea which may or may not works.
Liberty Media is due to spin off its non-Starz related assets, i.e., its media investment assets in Sirius XM, Live Nation, Barnes & Noble, minority interest in Time Warner, Viacom, Sprint, etc.
According to this press release (http://ir.libertymedia.com/releasedetail.cfm?ReleaseID=732276), persons acquiring Liberty Media common stock in the market through Jan 11, 2013 will receive shares of Spinco common stock in the distribution. So people who buys LMCA at $122 today will still qualify for shares in the Spinco.
And the Spinco stock is now traded on as "when-issued" basis on Nasdaq under the stock code, LMCAV (http://www.nasdaq.com/symbol/lmcav). "When-issued" refers to the stock price as if the stock is selling on the day it is ex-dividend or ex-distribution or rights. It closed at $108.71 yesterday.
So if you buy LMCA at $122, and on Jan 14, 2013 (coming Monday) when it is ex-distribution and if the actual price then really tracks the "when-issued" price of $108.71, you are actually paying $13.29 per share of Starz stock.
Upon completion of spin-off, there'll be about 124 million outstanding common stock in Starz. Starz makes $240 million in 2011. Thus, eps is $1.93. At the price $13.29, it priced at 6.88x earnings - a value too low compared to other cable companies like AMC Network (>17x) or Discovery Communications (>20x). Even if we use a conservative valuation at 12x eps, it is worth at least $25.
So by paying $122 today for LMCA, you get 1 share of Starz on coming Monday. If you can then sell the non-starz stock on Monday at the same price as the "when-issued" price traded last night at $108.71, you are only paying $13.71 for each Starz shares which produces earnings of $1.94 per share.
Easily, you can almost double up your capital of $13.71 to $25 based on 12x earnings of Starz.
Disclosure: I bought some LMCA at $120.7.
Intelligent Investing
"It's (Value investing) like an inoculation. If it doesn't grab a person right away, I find that you can talk to him for years and show him records, and it doesn't make any difference. They just don't seem able to grasp the concept, simple as it is."
Friday, January 11, 2013
Friday, January 04, 2013
Review of Portfolio for Y2012
Let's
start with recent comments from Seth Klarman:
'The
key watchword for the first half of the year [2012] was patience. We
patiently sifted through scores of interesting investment ideas to
find only a few really good ones. We patiently held cash while
waiting for prices to hit our buy levels before accumulating. We
stayed abreast of the U.S. markets where most of our investments
reside, while patiently searching European markets for the occasional
morsel, despite the frustrating reality that most sellers continue to
cling tightly to their troubled assets--at least for now. All the
while, we built up our knowledge of European markets, country by
country and asset class by asset class, while expanding our base of
relationships and developing price targets for many businesses and
assets that we would love to own at the right valuation, awaiting a
reckoning that we deem likely to come but at a date uncertain.' -
Seth Klarman
We
agree patience is key particularly in times when few investments are
available to deliver an above-average historical return. But a lack
of good investment opportunity does not mean the next move is
downwards for the market. With huge liquidity flooding the system, we
can understand why the market is going up. Fed, for one, is pumping
$85b a month ($45b on long term treasury and $40b on mortgage backed
securities) into the system, although in the latest Fed's minutes, it
hinted that stimulus may be ended earlier than expected. That is over
a trillion dollar of monetary stimulus that is rushing into the
market annually. Couple with ultra-low interest rate which is
expected to be near zero until unemployment rate reaches 6.5% or
below, there is little places to stash one's cash for a decent but
risky return. For those who keep cash, it has less buying power as
time passes. Thanks to the Fed, savers find themselves subsidizing
enterprises and corporations. It is essentially a transfer of wealth
from savers to corporations. Just that it is done stealthily. Not
only is it done stealthily, but it also punishes the responsible
savers while rewarding and subsidizing those who took excessive risk,
bought houses they could not afford or had otherwise ran up too much
personal debt. For savers who realize they are “conned,” they may
then opt to invest in other asset classes like corporate or sovereign
bonds or even equities just so that they do not get “conned”
again. That's why we hear more people saying it is better to buy
dividend assets than to have cash. Eventually, these savers may find
themselves getting “conned” again by the macroeconomic policies
which had driven or “coerced” them to invest in such assets
classes so just that they are able to maintain their real net-worth,
which they otherwise would not have had interest rate been more
normal, when things come to a head. This is exactly the time when
things get more risky when everyone is heading in the same direction.
In short, investors are hugely influenced by what Fed does. Today,
Fed is telling us to go forth and speculate and I don't care what you
buy as long as you buy.
Given
the current situation, we think it is hard to short the market given
that the liquidity have to go somewhere, at least for the short term.
With stimulus, not only monetarily but also fiscally, couple with low
interest rate, many are enticed or “forced” to get invested so as
not to see their “real” net worth gets decimated by the negative
real interest rate. Negative real interest rate is likely to persist
for some time and thus, we can understand why people are putting more
of their savings in assets that provides better yield than normal
savings interest-bearing account.
Although
we doubt the market will suffer a big crash any time soon, that does
not mean it would not. We are mindful that the possibility of a
correction is always there. Washington has simply deferred the fiscal
and debt ceiling issues. End of February, Congress must boost the
federal borrowing limit. On March 1st, $110 billion of sequestration
or automatic spending cuts begin slicing into defense and domestic
spending if no deal is reached. By end of March, a government
shutdown looms unless Congress approves funding for government
operations for the reminding of the fiscal year, which ends Sept 30.
Without action, many federal employees could face the possibility of
being furloughed. Although Washington is dysfunctional and has
provided band-aid fixes so far, we believe Winston Churcill is right
when he said: “Americans
can always be counted on to do
the right thing after
they have exhausted all other possibilities.”
But we do not know if they are at the end of the road yet or still
has more possibilities to exhaust and drag for more time.
So
all these are affecting business decisions who typically plan on a 3
or 5 year basis. How do we expect businesses to plan if they do not
know what is going to happen in a few months? But regardless,
liquidity is flooding the market and there is some tailwind behind
the U.S. economy driven by the housing and automotive sectors. Annual
U.S. automotive sales may potentially even rise to pre-recession
highs.
But
what is likely to happen two or three years from now when
unemployment hits 6.5% or even 6%, when monetary support is
withdrawn, would the economy be able to stand up on its own, how
about inflation, and how about when interest rate goes up? We do not
know the answers and do not attempt to be part of the jury. We just
play to our strengths which is to look on a bottom-up basis. For us,
we think capital preservation is more important than to rush into
deploying capital so just as to maintain our real net-worth. We fear
the alternative may be worse when things come to a head. Because in
times of chaos, cash is probably the only asset that is certain to
hold up the best in terms of value which you can then use as the
currency of choice to purchase what others deem as trash and risky,
and thus rush to sell regardless of the underlying value.
An
investor who invests just based on the relationship between interest
rate and inflation in order to maintain their real worth is missing
another ingredient to the equation: risk. Example, for bonds, prices
are high but yield is low though it meets savers' goal of exceeding
banks' savings interest rate but the proposition is risky with
current bond prices. Part of the risk facing investors is that the
math on bond prices and yields means it won't take much higher yields
to inflict substantial capital losses. With 10-year Treasury yielding
1.7%, a one-point rise in yield would lead to a 9.2% decline in the
value of bonds. For investment-grade corporate-bond index of 5 to 10
year notes, a one-point increase in yields would cause a 6.4% drop in
bond value. So in chasing to maintain real “net-worth” may or
will ultimately cause one to worth less.
So
investors find themselves between a rock and a hard place, facing
either the likely but limited erosion of purchasing power that
originates from holding cash, or the uncertain but potentially
disastrous impairment of capital that arises from owning overvalued
equities or bonds. Both are unappealing choices but we prefer the
former.
And
what makes this choice harder is how long will the negative real
interest rate last, this will make a difference to an investor's
choice in equity or cash. There's no easy answers to the problem of
real capital preservation in an age of financial regression, only
difficult choices.
Depending
on how long the financial regression lasts, if we assume it is
short-lived, then it may be wise to be underweight equities and
conserve capital and wait a riper opportunity set by out-compounding
the drag of inflation and negative real interest rates.
We
do not know when market will bust and neither do we intend to time
the market. We just simply play to our strength and evaluate equity
by equity and if the price is good, we will buy it, regardless of
economic condition. That is why we build up our cash position in the
second half of 2011, peaking at 43% at end of 2011. But our cash
position has since dropped to 27%. Now you may question why did it
drop so drastically when we think there is both a lack of good
investment ideas and our intent to patiently hold cash until we find
a good investment. Here's the caveat: a lack of good ideas doesn't
mean there isn't any, we were fortunate to identify one area of
interest. So, substantially all of the drawdown of cash were spent on
two positions – Mastercard and Visa. Had we not spent on them, our
cash position would have increased. Thus, if we exclude Mastercard
and Visa, cash would have increased by 15 percentage points.
Portfolio
Performance (all results are based in terms of USD)
Figure
1.
We
added a new table (figure 2) to show the performance purely on our
equities:
Figure
2.
Our
portfolio return 16.5% for the year versus S&P500 13.4% (as can
be seen in figure 1). This is the 5th consecutive year we
are ahead of the most broad-based USA indices. We hope it is not
fluke and we endeavor to keep our eyes on the ball and the field, not
the scoreboard per se.
We
changed the starting date to measure our performance in year 2008
from 1st January to 1st May because it is the
actual inception month of our portfolio. Had we maintained January
for comparison, our portfolio would outperform S&P500 by 26.8% in
Y2008, compared to 23.1% from May 08 to Dec 08.
Although
we perform well this year even with substantial cash position, we
underperform the Singapore Straits Times Index by almost 11%. Most of the underperformance can be attributed to the fact that we are
overweight on U.S. dollar assets. Figure 3 shows our distribution of
assets:
Figure
3.
We
are not concern about outperforming the benchmarks year after year,
although we understand it can be irritating not to. Instead, we aim
to outperform the major USA and Singapore broad-based indices over a
full economic cycle. Even though, we may lag the STI index by a huge
margin in 2012, we have however outperformed the index by an
aggregate of almost 78%, even with 3 years of underperformance out of
the 5 years since our inception in May 2008. We tend to outperform on
the downside than on the upswing. Our portion of Singapore equities
returned 23.1% against STI 27.4% (as can be seen in figure 2).
Capital
preservation is the most important thing to us. We will grow it with
the appropriate risk-adjusted return by managing risk rather than
swinging for the fences to maximize profit at all cost. We do not
have the gut to stomach significant losses. At times, we will make
mistakes, we are sure of that, but we will try to keep it at bay.
What
drove our returns?
Figure
4.
From
figure 4, we can see the top 3 drove 66.8% of our equity gains in
2012:
- MasterCard and Visa – As a group, up 34.4% and makes up 43% of the total equities gain for the year. Individually, MasterCard is up 32.1% while Visa is up 47.3% and comprises 34.3% and 8.7% of our total equities gain for 2012.
- Berkshire Hathaway – Up 17.7% and comprises 19.3% of total gain.
- UOB – Up 31.4% and makes up 13.1% of total gain.
We started the
year with Berkshire Hathaway, PepsiCo, and UOB as the top 3 equity
positions – which makes up 69% of all equities held at the start of
the year. We did not own any Mastercard or Visa then. So 2 out of the
top 3 starting positions are the major drivers for this year
performance.
Mastercard and
Visa, which we bet aggressively by using almost 44% of our starting
cash ended comprising about 20% of our total portfolio, at the peak
(15% at end of 2012).
As for PepsiCo, we
sold all of it by May, at a modest gain from our cost.
Portfolio
Discussion
Figure
5.
We
ended 2012 with 21 equities, compared to 10 positions in 2011. Our
top 3 positions makes up almost 40% of total portfolio; top 5, 49%.
Excluding cash, top 3 makes up 54% of all equities, and top 5, 67% of
all equities.
Discussion
on equities
- Berkshire Hathaway: Our largest equity position comprises almost 17% of total portfolio. Berkshire is our longest holding stock. Although we adjust the position size from time to time, depending on value or alternative, we have maintained our current position size since May 2011.We bought our first share in Oct 2008 at a cost of $57. We think there's not much downside to the current price. BRK is prepared to repurchase shares at 1.2x of reported book value which is about $89 – $90 based on 3Q numbers. In fact we think the stated book value is substantially below intrinsic value. For example, Burlington Northern Santa Fe was purchased in 2010 for $34 billion. BNSF is expected to earn $3.5 billion in 2012. Using a multiple of 15x earnings (same as Union Pacific), BNSF is worth $54 billion. If accounting rules allow writing up of goodwill, then BRK book value will increase by $20 billion. Based on BNSF alone, the stated book value as of 30 Sep 2012 is at least 10% less if we include the $20 billion increase in BNSF's value.For more details on BRK valuation, we think Whitney Tilson provides a good presentation on it. You can google for it. In the past, we have made some money from Tilson's idea – Anheuser-Busch InBev, although we sold it early. He was spot-on on that, in fact, BUD went even further than what he thought will sell for – currently BUD is selling for $87 versus his target of $72 or so.
- Mastercard and Visa:
Figure 6
We bought
Mastercard and Visa in two batches – January and May 2012. We
allocated 56.4% of the total capital during January 2012, all on
Mastercard at an average cost of $350.43. Subsequently, we added
more and allocated the rest of the capital related to them during
May 2012: at an average cost of $408.3 for Mastercard and $116.56
for Visa. Our average cost for the two batches of Mastercard is
$368.15. Subsequently, we reduce some of the holdings, Mastercard
was reduced by 33.9% and Visa by 12.8%. As a result, our average
cost for the rest of the shares remaining at year end is $383.37
for Mastercard and $119.44 for Visa. In addition to selling our
holdings, we did some rebalancing between the two counters during
year: for example, when Visa is cheaper than Mastercard, we sell
some Mastercard to hold more Visa, so it resulted in a higher
reported average cost per share in Visa at $119.44 than the
original cost of $116.56 but overall, it benefited our holdings
than if we had not rebalanced.
At year end, both the stocks
comprise about 15% of total portfolio with Mastercard making up
about 12.4% and Visa 2.7%. Both have about the same potential
medium term growth – 15 to 17%. But Mastercard is priced slightly
cheaper than Visa. At current price, we think both are fairly value
at 19 to 20x forward earnings. We won't be expecting any outsize
return from them. But they should still bring us reasonable return
simply by rising at the same rate as earnings without relying on
any expansion in earning multiples. Even if the price remains the
same a year from now, we think it provides a good entry point to
add more given that the then valuation is likely to be less than
17x on a forward basis. If either one of them falls, say by 10%, in
a year time, we will shift more of our assets into them because
valuation would likely be close to 15x forward earnings.
We think
the long term prospect is very bright – payment is in a secular
growth market. More transactions in the future will be done
cashless, especially for market outside of the U.S. where
transactions are still largely done in cash. In U.S., 29% of all
retail transactions are in cash, down from 36% a decade ago.
According to Mastercard, 85% of all global transactions are in
cash. The huge gulf in cash transactions between the U.S. and
globally lies in the emerging markets. Cash still largely prevails
in emerging markets because of the slow development in electricity
and communication infrastructures. However, smartphones and
wireless networks should help to bridge these physical
restrictions.
There are a lot of competition in the payment sector
from PayPal operated by Ebay, Google Wallet, Square, among others.
But all of them operates in the digital wallet space, essentially a
locker of personal-payment data stored either in the cloud or on
smartphones. None of them have made a dent to the network
infrastructure that facilitates the actual flow and transfer of
money between merchants and financial institutions in the credit
and debit space. PayPal acts as an acquirer which is the
institution that acts on behalf of a merchant to process debit and
credit payments. And acquirers need the network infrastructure such
as Visa to facilitate flow of payments between the merchant bank
(acquirer) and the customer banking facility (the card issuer) –
just like if you and me want to talk on the phone, we need the
phone operator and Mastercard and Visa is the phone operator in the
payment space. Mastercard and Visa also have their own operations
in digital wallet, called PayPass and V.me. But when it comes to
routing transactions, essentially the infrastructure that connects
and sits between the merchants and banks, Mastercard and Visa are
the dominant players.
Digital wallet, despite all the hype, has
thus far done little to alter the relationship that has been built
around credit and debit. Compared to Amex and Discovery Financial,
Mastercard and Visa have lesser business risk, though it may be
riskier for an investor in terms of the higher stock valuation –
Mastercard and Visa sells for high teens to low twenties multiple
while Discovery and Amex sells for high single digit and low teens,
respectively. Amex and Discovery, like Amex, in addition to
providing a payment network also provides financing to their
customers, so they have more risk associated with credit. Whereas
for Mastercard and Visa, they are pure-play payment network. Their
revenue comes from fixed per-transaction fees, service fees based
on transaction size, and fees for cross-border transactions. Visa
and Mastercard make about 10 cent for every $100 transaction.
So even if there is inflation, we think Mastercard and Visa
provides very good hedge.
Adding to Mastercard and Visa moat is the
trust that exists between the banking institutions and them, which
essentially allows them to reach into customers' banking accounts
and subtract money. And banks like the status quo especially when
the banks take most of the fees that flow through the card
networks. In effect, the banks play a big part in protecting the
domain of Mastercard and Visa. Moreover, their business model held
up extremely well during the 2009 crisis, revenue for both rose -
Visa by 9% and Mastercard by 2% - with operating earnings rising at
a much higher pace. It was the first time their business model is
tested as a public company and they passed with flying colors.
Although the shares were sold off at that time, investors now know
how resilient their business model is. So even if there's a
recession, we think Mastercard and Visa is likely to hold up much
better than the last time and better than most other businesses.
Even in a recession, we think they should be able to deliver growth
in earnings per share because they have a number of levers to pull.
For example, both of them are essentially free of debt, so if they
want to orchestrate a huge repurchase of shares, it is one lever to
use. In fact, we will be happy the shares plunge so that we can buy
more while the companies are also buying back an undervalued share.
Another lever is they can easily cut back on expenses especially
marketing related – the kind of expenses that can easily be cut
in a downturn – that is what Amex did during 2009, so if Amex
can, we are sure Mastercard and Visa are able to as well.
- DirecTV: 57.4% of the positions are purchased at an average of $44.22 from Dec 2011 to May 2012, and the rest were acquired in October 2012 at an average of $51.43. We recycle part of the proceeds from Mastercard and Visa in DTV during October. At $51, stock is priced at 10x 2013 earnings. We think it trades at a significant discount to intrinsic value and offers steady, leveragable cash flow, exposure to Latin American growth and sound capital discipline. DTV started the year as our smallest equity position with less than 2% of total portfolio. But it ended as our 3rd largest equity position with slightly over 10% of total portfolio.We think DTV is one of the cheapest play within the pay-tv sector, whether we use the traditional PE or EV/EBITDA valuation. Dish Network, a pure satellite pay-tv play, is the closest comparable that sells for 15x earnings, almost 50% more than DTV valuation. For others, like Time Warner Cable, sells for 14x earnings. However TWC is more than pay-tv, it provides internet and phone services as well, which provides an advantage over pure CATV play since TWC can provide so-called “triple-play” package to entice new sign-ons and also provide a leverage to reduce churn rate. But is “triple-play” advantage worth to pay 40% premium more? We are cheap so we will play it cheap and hopefully, the difference in valuation will close up in DTV's favor.
- IBM: Makes up 7.1% of total portfolio. All of the positions were initiated in 2012 between $180 to $198, at an average cost of $193.18. We think IBM has a good chance of performing well in 2013 partly because of the easy comps which reset the forward benchmark to a lower hurdle to cross, in terms of the Street expectations. We also like that about 60% of IBM profit is recurring nature due to its large software (23% of revenue) and services (58% of revenue) that have longer-term multiyear contracts. As a result, its business performance have been less volatile and more predictable than most.But one of the things we did not like is the way it reported earnings in Q3 when its reported adjusted operating earnings include a one-off gain from the sale of a line of business to Hitachi. If it is a one-time gain, why is it part of adjusted operating normal profit? We cannot understand except to the extent that the corporation try to mask the underlying performance and hope that others miss it. And none of the major news media spotted it, or at least reported it. Nonetheless, we still think IBM should perform decently for the next few years and has a reasonable chance to achieve its stated roadmap of $20 of operating earnings in 2015. But we will keep a close look on them quarter to quarter on the reporting and underlying fundamentals.
- Stocks that makes up 2 to 3% of portfolio: We hold 5 stocks which each makes up between 2 to 3% of total portfolio each. In total, these group makes up 12.1% of total portfolio. The 5 stocks are Visa, UOB, Dollar Tree, Johnson & Johnson, and IAC/Interactive.
- UOB – We bought it during Q3 of 2011. We have reduce 2/3 of our UOB holdings this year. We don't think it is expensive, especially compared to most other STI components. It has roughly played out as what we think it should have. The bank has grown its asset base as we think it can. If return on asset returns to 1.2 to 1.3%, it can earn between $1.75 to $1.9 based on $230 billion of assets, valuing the current price at 10-11x earnings.
- Dollar Tree: We acquired during Oct 2012. Up less than a percent. Stock is down quite significantly from the high. In fact, all the Dollar stores are way off from the high, and valuation are roughly the same among all the three – Dollar Tree, Dollar General and Family Dollar – valued at about 14x forward 12 months earnings. For us, we are more attracted to Dollar Tree because it is the least leveraged and has the lever to pull on that basis if needed or maybe it will appeal to certain private shop given the low leverage and strong cash flow.
- IAC/Interactive: Acquired in Q4 at an average $48.27. Down 2% so far. Usually we do not invest in technology but we think IAC provides good value for the type of growth it guides for. Sells for 13x earnings, and 11x ex-cash for 2013 earnings. We also like that Barry Diller is the head of the company. We think of Barry Diller in the same breath as John Malone – both of whom have proven to unlock value and deploy capital efficiently.
- Johnson & Johnson: JNJ is the second longest holding in our current portfolio. We have held them since 2010. Up 6.9% in 2012 and up 14.6% from acquisition.
- We own another 12 equities which in total makes up 14.9% of total portfolio. Following are the equities:
- Tesco: Acquired in January 2012 at an average cost of US$4.94 – up 13.3%. If we did not elect to take one of our dividend in script, we will up 9.8% instead.
- CSX: Acquired in Q3 2011. Up 2.6% for the year and up 9.3% from cost. We reduced over 60% of the positions during February 2012. Results has been tepid mainly due to the depressed natural gas prices which drive lower demand for coal. Although coal makes up a huge chunk of CSX business (over 30%), strong growth in automotive and intermodal has largely offset the decline in coal volume.
- Celgene: Acquired in May 2012 at a cost of $71.34. Up 10.2%. We reduced 46% of the positions in October 2012. However, we think still Celgene should provide decent return. If EMA approves Revlimid as a first-line treatment for Multiple Myeloma, it should give some tailwind to the stock. Even if it doesn't, Revlimid is already prescribed off-label as a treatment for MM in Europe. Also, Celgene has some recent success in clinical trials for the cancer drug, Abraxane, resulting in approval for extended use in metastatic non-small cell lung cancer. There are other trials in the pipeline for Abraxane for other form of cancers, for example, pancreatic. We think there's a decent chance in will sell for $90, for 16x 2013 earnings.
- Norfolk Southern: We initiated NSC in the first two months of 2012 and ended comprising over 5% of our portfolio at that time. Subsequently, we reduced 70% of our holdings in the middle of 2012, at a modest loss of 1%. The cost for the remaining shares is $71.4, down -13.4%. Inclusive of the shares sold, we are down – 4.7%. Norfolk Southern has basically the same business model as CSX in which coal is pressurizing the underlying business. We think a lot of the bad news are priced into the current price. To go much lower, we think the economy needs to stop in its track.
- Coca Cola: We sold all of our Coca Cola shares in the middle of the year and then again initiated a small stake in Dec 2012 for $36.49. The earlier stakes were sold at a gain of 12%, which were acquired in Nov 2011 and Jan 2012 at an average price of $33.38. We think the current price is a reasonable entry point to pay for a business of Coke quality at 16.7x 2013 earnings. Together with the earlier stake, Coke returned 8.9% for the year, and 11.2% from cost basis.
- American Express: Bought in Oct 2012 at $56.75. Up slightly at 1.3%. Valuation is not particularly demanding at 13x 2012 and 12x 2013 earnings.
- National Oilwell Varco: We did not pay much attention to the oil and gas sector (especially contractors that serve the exploration of oil) until August this year when Berkshire Hathaway initiated a position in the stock. The stock then was selling for over $80 a share and peaked at $89.95 in Sep 2012. Then it fell to about $80 and generally sells between $77 to 83. It took a big correction in December 2012, falling to a low of $64.82. During the time from August to December, we spent some time familiarizing with the oil and gas sector, particularly on the upstream operations including on and off-shore drillings. Fortunately, our time spent paid off somewhat when NOV fell below $70, a price we think provides a good entry. We finally took a small bite and acquire some at $66.9. NOV is the dominant equipment provider for oil and gas drillers, both onshore and offshore. Its share grew by 5-folds in the past decade largely due to its success in persuading drillers in the early 2000s to shift from custom-built rigs to rigs built around its own standardized components, according to Morningstar analyst Stephen Ellis. Today, an overwhelming majority of rigs use NOV's parts. Vendors cheekily called them: “No other vendors.” NOV is largely dependent on energy prices which drives drilling activities. If oil prices doesn't support drilling activities, NOV business will be adversely affected. However, NOV is among the safest energy plays because it serves both the oil and natural gas explorers and drillers, and also both on and off-shore drillers – they are kind of energy agnostic. At $67, it is selling for 11.4x 2012 earnings and 10x 2013 earnings.
- Singapore Telecom: Bought in Oct 2012 at US$2.58 or SG$3.15. Up 4.6% since or up 6.8% if we include the dividend that just went ex-div in December 2012. We think SG$3.15 is attractive relative to other Singapore stocks. The price was also temporarily driven down when Temasek sold part of their holdings. The selling is now over and price has recovered a little. But we are not a long term holder in Singtel. It is just a relatively safer alternative in a market that is otherwise expensive.
- OCBC: Acquired in August 2011 at a cost of US$7.56 or SG$9.11. Singapore banks staged a remarkable recovery in 2012. We sold half of it in June 2012. Our holdings is up 24% for the year, but is down 1.3% from our cost.
- M1: Bought early this year at US$1.95 or SG$2.43. Up 14.5% for 2012. We sold half of it in Dec 2012.
- Thai Beverage: We purchased the shares in November 2012 for US$0.33 or SG$0.40. We don't usually invest in stocks which have surged a lot in a year or is near to the all-time high. However, for Thai Bev, we have always like the stock since it was listed but we have never own it until now. In fact, we nearly bought last year when it was selling for SG$0.24 but we were cheap and queued to buy at SG$0.235. For half a cent difference, we miss a huge gain. The other comparable mistake of such is how we miss buying Mastercard and Visa during Dec 2010 and during part of 2011 when we were sucking our thumbs. For Thai Bev, even though the stock is close to its all-time high, we think the valuation is not demanding. It is selling for 16x earnings. What we like is their spirit business which is growing at a good clip, although other parts of the business is holding them back. Compared to other spirit businesses like Brown-Forman and Beam, they are selling well in excess of 20x earnings.
- Marvell Technology: Our biggest loser for 2012 in terms of percentage, and ranks among our all-time biggest losers. We bought at $10.05 and is down by -27.8%. If there is any consolation, it is one of our smallest equity positions. However, we will be holding on given that the price has likely priced in a lot of the bad news which we failed to factor into our analysis. What we thought initially as cheap is perhaps cheap for a reason and probably a value-trap at the time of our purchase. MRVL has about $3.5 a share in cash, so we thought at $10, is selling for 7-8x earnings ex-cash, and if demand for MRVL products recover, it is selling for 5x earnings ex-cash.But what really went wrong for us is not so much on being wrong on the earnings but because we were surprised at how much MRVL is fined when it lost its suit on patent infringement and was fined $1.17 billion for actual damages. Because the infringement is deemed willful, the fine could increase by 3x. In any case, MRVL is appealing, and could overturn the order eventually or lessen the fine tremendously. However, if it doesn't, MRVL hands will be weakened. But we think the fine is outrageous in relation to MRVL revenue and profit. It is one-third of MRVL revenue or 100% of revenue if the punitive damages is levied at 3x of actual damages awarded. We think there's a good chance the actual damages will be eventually reduced.
Google
We foolishly sold
our Google stock as it went up. We fail to get the entire rise. We
bought well but we need to improve our selling. But we did decently
for the short holding period. This is the second time we held and
sold Google. We hardly invest in technology companies
primarily because of their often high stock valuations due to rapid
growth, and potential for obsolescence due to rapid change in
technology. The last thing we want is to pay a high price for a
rapidly growing business that gets swept aside by new technology
shortly after we buy it. Bearing this in mind, it doesn't mean we
wouldn't buy it at all costs. We will buy at the right price,
especially at a bargain price. Any time if Google gets back to $600 -
$650 range, we will be there to buy. At $650, we will be paying about
14x earnings, less if we exclude the cash. Even at $700, it isn't
expensive at 15x eps or less than 13x ex cash. It is hard to find
companies with market leading positions secured by strong competitive
advantages in secular growth markets because such companies do not
usually sell at market multiples. And Google is one such find today.
And this is a business that has top line growth of 20% per year. We
will discuss more if we ever get another chance to purchase Google.
Sometimes we make silly mistakes selling our holdings where we will
be much better, in fact, a lot much better, if we had not sold.
Google is another stock we made a mistake selling in addition to our
recent other mistakes – Davita, Anheuser-Busch Inbev and Amgen. All
of which we bought well but sold atrociously.
Opportunistic
situations
We only managed to
find take advantage of one opportunistic situation when Monster
Beverage took a big heat to its shares in October 2012 when there
were some complaints to FDA that Monster drinks led to some death on
over caffeine consumption. We think it was a “tempest in a teapot,”
to borrow Jamie Dimon's infamous quote. So we purchase some shares at
$42.8 and sold within the same month when the price recovers some of
its losses and lock in gain of 10%. Stock has since surged to almost
back to the pre-plunge price of $51 to $55. Again, we were early in
selling.
Stocks we are considering
Baidu
We
do not usually talk about companies we like that we do not have a
position. Baidu is selling for about $100,
down by a third from the peak more than half a year ago. Now, it has
come to a price we are comfortable in for a growing business. Baidu
business is likely still to be in the early innings. Earnings is
expected to grow in excess of 20%. Valuation is less than 17x for the
next 12 months earnings. If we exclude cash, p/e comes to 15x. For a
business that can grow at mid to high teens level for the medium
term, we think paying 15 to 17x earnings is a good deal. One of the
concern was its market share is eaten up by competitors like Qihoo.
Baidu's market share is down to about 60% from its peak of over 70%.
Baidu's market share used to be in the high 50s to low 60s prior to
Google's exit a couple years ago. Upon Google's exit, Baidu market
share went to over 70%. Now it is back to where it is.
American Movil
Stock is having a rough time and is selling close to 52-week low below $23, priced at 13x earnings. Its domination in Latin America is under pressure from government encouraging more competition, including its homes market, Mexico. We think the price is pretty attractive.
American Movil
Stock is having a rough time and is selling close to 52-week low below $23, priced at 13x earnings. Its domination in Latin America is under pressure from government encouraging more competition, including its homes market, Mexico. We think the price is pretty attractive.
Valeant Pharmaceutical
We think the business is well managed led by one of the smartest mind in the pharmaceutical industry. Valeant pursues a different path from most other large pharmaceuticals. VRX does not spend a large percentage of its revenue on research and development (low single digit versus low to mid teens for major drugs discovery firms) but instead grows through savvy acquisitions that accretes to earnings, sometimes, significantly. They have had much success in the acquisition arena. Even at $60, its all-time high, it is priced at 14.5x 2012 adjusted earnings. It is a rare pharmaceutical that is growing top line and bottom line at such a fast clip at over 20% and 30%, respectively. Although most of the most of the revenue growth came through acquisitions, organic growth is still an industry-leading one at high single to low teens level. Effectively, VRX is a master value investor within the pharmaceutical space. The reason VRX is able to do that it is led by the able Michael Pearson, who has been an extraordinary and aggressive CEO. VRX is a rare find in any industry, which is both a value investor and a savvy operator. The other comparable we can think of are Berkshire Hathaway, any of the Liberty-related companies and Barry Dillar-related companies.
We think the business is well managed led by one of the smartest mind in the pharmaceutical industry. Valeant pursues a different path from most other large pharmaceuticals. VRX does not spend a large percentage of its revenue on research and development (low single digit versus low to mid teens for major drugs discovery firms) but instead grows through savvy acquisitions that accretes to earnings, sometimes, significantly. They have had much success in the acquisition arena. Even at $60, its all-time high, it is priced at 14.5x 2012 adjusted earnings. It is a rare pharmaceutical that is growing top line and bottom line at such a fast clip at over 20% and 30%, respectively. Although most of the most of the revenue growth came through acquisitions, organic growth is still an industry-leading one at high single to low teens level. Effectively, VRX is a master value investor within the pharmaceutical space. The reason VRX is able to do that it is led by the able Michael Pearson, who has been an extraordinary and aggressive CEO. VRX is a rare find in any industry, which is both a value investor and a savvy operator. The other comparable we can think of are Berkshire Hathaway, any of the Liberty-related companies and Barry Dillar-related companies.
VRX is able to generate the types of returns it drives through acquisition largely because of the cost cutting it can achieve in the range of 15% to 20%. As an example, when Valeant merged with Biovail, Biovail was doing a billion dollar sales and in 2012, VRX is targeting to eliminate $300 to $350 million (35% sales) through synergy. So a lot of the $300+ million flows to the bottom line because of the company's low tax structure. In 2011, VRX acquires a number of bolt-on acquisition which in aggregate adds another billion of sales and targets for 25% synergy. Again, a lot of the $250 million is going to flow to the bottom line. So in effect, VRX is generating really high returns by acquiring other businesses in the pharmaceutical industry. VRX has also announced its plan to acquire Medicis which will close in 2013 in a friendly, all-cash deal. The deal will make VRX the largest player in dermatology in the U.S. We like it at $45, and we like it at $50, and now even at $60, we like it, although we have never own it. We intend to and at $60, it is priced at 11x cash earnings.
Of all the 3 stocks listed here where we are interested in, we are most comfortable with Valeant the most.
Sunday, July 01, 2012
Portfolio update for first half of 2012
What
a dramatic last three trading days to close the first half of the
year on a high note! S&P500 is up 8.3% for the first half, or
over 16% annually - which by any measure is a great result - double
the historical growth rate. Stock prices have been steadily ascending
since October 2011, boosted by a whiff of hopeful recovery in the
U.S economy, a seemingly claim state amidst the sovereign-debt storm
in the E.U., merrily cheered on by central bankers with near-zero
interest rate and hoping for further easing.
Here
is an oxymoron: The job of an investor or money manager is not to
make money but to manage risk because once you take care of the risk,
you take care of the rest. One of the most important job in managing
risk is to measure the temperature of the economy and know where we
stand. At the moment, it is unwise to be fully invested unless one
can find something that is totally uncorrelated to the market.
However, even in a expensive market, there're still value buys on a
bottom-up basis because the market is never fully efficient – just
a matter of degree.
If
you are an individual in debt, what would you do to solve your debt
problem? Would you take on more debt to pay your old debt? No, you would not. Would taking on more debt to pay your old debt solve your problem? No, it does not. The only way to solve
your problem is to cut your expenses and pay down your debt. Or you
can chose to default and break your obligations which were granted on
the basis of trust in your ability and goodwill to repay the loans.
Essentially, those people in debt need to stop spending money that
they do not have. So why should it be any different for a sovereign
country? The solution to too much debt is not more debt.
Sooner or later, something have to give and people start facing the
ugly truth. The highly-in-debt country may just chose to default on
its obligations, either directly or indirectly. By indirect manner, a
country can print more paper currency to pay the interest which makes
the currency worth-less if the debt are issued in their own currency.
A direct or outright default happens when a country simply stop
making payments for their obligations – and there's no recourse to
claiming from a sovereign country: you can sue a company for
defaulting and claim its assets in court but for a sovereign country,
how do you sue for a country's assets? Bill Gross and Jim Rogers are
two proponents who question the solution of using more debt to solve
a debt problem. All these look like a band-aid solution for which
every time the policy makers gave such a solution, the market jumps
on the hope of it being a panacea but after a while, real questions
set in and bring the market to where it was before. How many times
have this type of scenario been played over the past year or so?
Here
are some recent quotes from Bill Gross:
- “Lots of money being printed but very little wealth. Wealth comes from innovation and elbow grease not higher asset prices.”
- “Don’t be fooled, central bank credit creation increases asset prices but it doesn’t create wealth.”
- “Wealth’s not cre8(a)d w(ith) high(e)r asset prices but w(ith) productiv(i)ty;labor;innovati(o)n. High(e)r asset prices due 2(to) lo(w) inter(e)st rates (a)r(e) fi(ct)ktitIio)us wealth.”
So
the question is what should we do now?
In
an up-market, some investors for “fear” of losing out may be
lulled into pumping more cash into equities. But in an expensive
market (top-down), there's a dearth of compelling cheap businesses
(bottom-up). So is the market now cheap , a value trap, or just
expensive? There are two ways that tells two different stories on the
same topic. By the traditional value method, a snapshot of the S&P500
shows a current multiple of 15x (based on trailing 12-months
earnings), which is not overly expensive in historical terms. But the
Shiller PE which is based on a 10-year moving average of earnings to
smooth out the impact of an economic cycle, shows an expensive
historical 24x.
So
why did the two measures differ so much apart? In a March 2012
article by James Montier of GMO, he noted a compelling point: The two
PE measures are derived from different time perspective. Profit
margins are an important determinant of earnings and Montier gave
mathematical evidence that the divergence of the two measures lie in
the result of profit margins deviating from their long-term normals.
That is to say, profit margin today is at historical high for U.S.
Corporates. In fact, it is abnormally high, hovering almost 2% points
over the last peak since 1952, according to NIPA Flow of Funds data.
Such a margin is unprecedented and has caused earnings to go through the roof, or perhaps “artificially” high. Some of the
margin improvements are achieved through synergy, cost cutting, labor
cost, etc. And there is so much you can do to cut your way to
prosperity. Not only is corporate profits at the highest ever, but wages as a percentage of GDP is at the lowest ever since post-war.
As an example, a small compression in margins can cause a big distortion to stock price, particularly if you purchase at the peak. Nike, which just reported earnings, is off almost 10% for the day when they reported a lower margin (not a lot lower but about 2% lower in gross margin). For those who bought at the peak of $115 thinking that margin cannot be compressed, and extrapolated from the recent past, this is a toxic cocktail. So they learn the old lesson the old way, through their wallets and is down almost 25% in less than three months.
Another
broad measure is taking the total market value as a percentage of
Gross Domestic Product. The broadest index to use is the Wilshire
5000. Using this index, the total market value of Wilshire 5000 as a
percentage of GDP is 106% as at June 30, 2012. There're two ways to
look at it again: if you compare since 1950s, 106% falls on the high
end of the spectrum; but if your vision is tunneled to just the
recent past since 1995, this is on the low end. But extrapolating
from recent past can kill you. The market has historically been
priced at 60-80% of GDP, it is only in recent past, particularly from
the 1995, did the percentage top 90% and above, peaking at over 170%
in March 2000. Here's a graph that speaks a thousand words.
World
Bank also compile their own data. You can find the data in this link:
http://data.worldbank.org/indicator/CM.MKT.LCAP.GD.ZS?page=4.
Unfortunately,
World Bank only have data from 1988 onwards but the trajectory,
whether World Bank or the first graph, are the same. Both also shows
clearly the difference in valuation 1) before 1995 and 2) after 1995.
The year 1995 was the first time in financial history that the U.S
has seen its total market value as a percentage of GDP touches 90%
and ever since, it has averaged well above 90%, except in 2009 when
it fell below 80% just for a moment, and stayed over 90% since. Now
some people may have gotten used to it and argue that 100% is on the
low end of the spectrum for the last 20 years and therefore, the
market is reasonable. Well, only time will tell who is right. For us,
we rather err on the side of caution than to be recklessly bold.
By
locking up the bulk of assets or capital in equities right now is
likely to doom your portfolio to a long-term return rate that is
historically unattractive and that grossly under-compensates you for
the risks assumed. More importantly, having limited cash at a time
when you should be having more means forgoing future opportunities
that are likely to be better than today's. And in a distressed
market, by selling stocks in order to buy other distressed stocks is
no bargain if your stocks are also in distress. The bargain comes
only if you have liquidity at the right time which holds water and
can be used to buy someone else's perceived trash (treasure to the
buyer), and exchange the cash, which in fact is trash at that time
but perceived as treasure by someone else. During the market low of
2009, sellers perceived their stocks as trash (treasure to the buyer)
and sold it in return for cash which they perceived as treasure
(trash to the buyer). The right thing to do then was the other way
round. We have seen this scenario played over and over again.
To
get good return and yet low risk, the best time to be fully invested is when market
is in great turmoil. At this point, potential return far outweigh the
risk assumed. This should be the hallmark of a prudent investor or
money manager. To join the rat-race chasing for return together with
your peers for fear of losing out or for the reason of looking bad is
not prudential. When we start to compare ourselves against peers or
even indices and only focus on comparing, it is easy to get lull into
operating on a relative basis rather than absolute one. Instead, we
must only focus on things that are truly important, especially risk
management. In investing, the only way to make money is absolute, not
relative – as they say “you cannot eat relative.” Perhaps some
people may feel good even if they lose money as long as they lose
less than the market. When they make 50%, you may think they are
delighted but for investors who get lost in relative performance,
they are not. They are likely to feel very terrible. Now, you may
think how can someone who makes 50% feels terrible? Lo and behold,
these relative investors are happy with 50% until they see the market
making 55%.
So
as an investor, you got to decide what you want to be. For us, we
focus on absolute return. To do so, we
follow our core principles as follows:
- We work on patience and maintain discipline by not chasing for return that does not sufficiently compensate for the risk we take - even if our portfolio lags behind the market in the short to medium run.
- We focus on doing what we think are the right things even if it looks wrong in the eyes of others, and not what looks right or relative.
- We do not look to beat the market all the time. We only look to beat the market at the right time, particularly, we aim to significantly outperform the market on a downturn and hope to maintain with, or even underperform the market on an upswing.
- We are dedicated to measuring our performance on a full economic cycle (i.e., a long market cycle that goes through thick and thin) against the market benchmark.
- We do not allow others to tell us what to buy, what to sell, when to buy or when to sell, especially on a baseless manner. Although we pay attention to what they say because it gives us an inkling what the market is doing and if what they are doing is sensible or not, and we position ourselves accordingly.
- We make our own decisions on how we think about the business and the value that is expected from the price we pay or sell. We eat our own cooking. Others who tell us what to do usually do not eat the cooking with us.
- We do not rely on others to measure our performance, we evaluate ourselves by what we say we will do in our core beliefs that will bring us long term performance excellence on an absolute basis.
You may ask what are the right things. It is impossible to clearly lay it all out. We can only say we know it when we see it - just like Judge Potter Stewart when explaining what is hard-core pornography, said: "I know it when I see it."
Armed
with the above, we, as investors, are at the crossroad facing a
fundamental choice on how to reach the final destination – do we go
slow or do we sprint? The first thing to recognize is investing is
akin to running a marathon. If you sprint, you may get ahead of
others at first, but losses your steam pretty darn fast. Thus, pacing
oneself is crucial. Remember, the Aesop's fable, “The tortoise and
the hare,” is just as applicable today as it was back then. And
today is one of those days you do not sprint, instead, keep your
breath and energy, and watch others sprint until they cannot. And
heaven forbids, you might even want to egg others on to sprint.
Despite
all the dramas, many of which unresolved, investors have hardly
balked even as we live in a more interdependent world. There are more
challenges to come in the second half including the “fiscal cliff”
issue. Eventually, something have to give and a band-aid solution
would work no longer. When the day of reckoning arrives, policy
makers can be counted on to do the right thing eventually. But it
will not be good for the securities market in general. That is when
we will be absolutely optimistic for the future: We are neither a
perma-bear nor a perma-bull. It depends on where we are in the
economy. Meanwhile, it is never fun waiting for the time to arrive,
and it is certainly not fun to be fully-invested when the day of
reckoning comes, but it is certainly fun when the day arrives,
provided you have bullets to shoot, so to speak. What dooms a man is
his failure to sit quietly in a room as Blaise Pascal observed all
along, and we are determined not to be such a man.
As
of 30 June 2012, cash as a percentage of assets is about 28% of total
assets, down from 32% at the start of year. We are very reluctant to
go much below this threshold based on current market conditions
unless we can find something really valuable. As we write, we managed
to increase by 4% in cash on the last trading day of the first half.
We will divest more stocks into cash if the market gets more
expensive, hopefully, it will. We are cheering for it although we
have the capacity to allocate into stocks, but we are net-seller in
this market.
Although
we hold a reasonable amount of cash, we have outperformed the major
U.S indices but underperformed the Singapore index. We did not deliberately aim to outperform in this market but our positions generated the returns that allows it to. In an
expensive market, we are satisfied to keep up with, or even
underperform, the market. It is in an upheaval market that provides
us with the best chance to outperform significantly in the safest
manner. In the game of investing, we wait for others to commit
unforced errors. We do not claim to have any special or better skills
than any other market participants. Charles Ellis, long ago,
described this phenomenon in his article, “The Loser's Game:” In
the game of investing, it has long ago turned into a game where folks
with ordinary intelligence can win as long as they wait for others to
commit mistakes. Investing is not a value-adding activity, it is a
zero-sum game: In order for someone to make money, someone else must
make a mistake. When you buy X security, someone else must sell you X
security. In the exchange, you as a buyer think X is likely to make
you money while the one who sells you X thinks it is likely to be a
loser. Who is correct? Someone must be making a mistake, it is either
you or the seller. As they say in Poker, if you do not know who the
patsy is on the table, it is likely to be you. Another word of
caution: in investing, it is relatively simple if you focus on the
right things and keep learning but it is not an easy game. Only a
fool will think it is an easy game.
Another hardly-asked question is how did the portfolio achieve its results. Most of us tend to just focus on the headlines. For example, if you compare the following arbitrary portfolios handled by different managers:
If we are to chose which manager to hand out money to, we will hand our money to Manager B. If there are only two choices - Manager A and C - we will chose C. Over our dead body will we ever chose A.
Another hardly-asked question is how did the portfolio achieve its results. Most of us tend to just focus on the headlines. For example, if you compare the following arbitrary portfolios handled by different managers:
- Portfolio A returns 50% in first half 2012.
- Portfolio B returns 2% in first half.
- Portfolio C returns 2% in first half.
- Portfolio A 50% return was largely achieved by placing a significant portion of assets in a "hot" stock with minimal revenue and has yet to generate any earnings to show for. However, it is "hot" and much pursued after by market participants because of its perceived attractiveness with novel technological capabilities that has the "potential" to grow exponentially.
- Portfolio B is up only 2% and underperformed the major indices by 4-6% because the manager deemed the current state of affair as risky, especially with a dearth of compelling buys. He, thus, allocated, less than 50% into equities, with the rest lock in safe havens like cash or short-term treasuries, while biding for his time.
- Portfolio C underperformed at the same rate as Portfolio B. However, the results for Portfolio C was achieved very differently from B. The manager for Portfolio C is almost fully invested, with only 10% cash or less. However, most of his equities turn out to be duds and most of the securities are not in safe-haven securities like consumer staples or the stable type of stocks. Most are in cyclicals. And it returns 2% versus the major indices return of 6-8%.
If we are to chose which manager to hand out money to, we will hand our money to Manager B. If there are only two choices - Manager A and C - we will chose C. Over our dead body will we ever chose A.
To
end this segment, here is a portion of one of our favorite poems of
all time which happens to capture the essence of successful investing
– “IF” by Rudyard Kipling:
Quote
If
you can keep your head when all about you are losing theirs and
blaming it on you.
If
you can trust yourself when all men doubt you but make allowance for
their doubting too.
If
you can wait and not be tired by waiting, or being lied about, don't
deal in lies, or being hated don't give way to hating, and yet don't
look too good, nor talk too wise.
Unquote
What
have we set out to do at the outset and have we accomplished it?
- Have we been conservative in a seemingly expensive market and be brave in a seemingly chaotic one? Check. Compared to early 2009 to mid 2011 when we were fully invested, we shifted gears starting mid 2011 to more cash, peaking at 35% cash, but has since dropped but we are still rather conservative holding 28% cash. We will increase or decrease depending on how hot or cold the market is, or if we can find cheap buys even if the market is hot.
- Have we been able to resist chasing after returns for the sake of keeping up with the Jones and be satisfied to underperform in an up market and outperform in a down market which is the strategy to long-term outperformance in a full economic cycle? Check. Our portfolio has so far shown the characteristics to underperform when the market takes a huge step forward and outperform when the market takes a huge step back. And over a period of time, we have delivered results that are satisfactory, and so far been absolute. Here are some examples:
- S&P500 is currently flat from the closing of April 2011 of 1363.61 (peak for 2011), while our portfolio is up 3% while maintaining a cash level of 25 to 35% for most of the period.
- S&P500 is currently down 3.3% from the closing of April 2012 of 1408.47 (close to the peak for the first half), while our portfolio is up 1% while maintaining a healthy cash balance of 25 to 28% for the period.
- In an up market, we are likely to underperform the benchmarks but we will not be unhappy, instead we are satisfied although it may be emotionally tough but we understand our goal. For example:
- If measured from market low: From end September 2011 (market low) to now, S&P500 is up 20.4%, while we are up 14.4% while maintaining a cash level of 15 to 32%.
- If measured from the high to the low in 2011: From end April 2011 to end September 2011, S&500 is down 17% while we are down 10%.
The above examples demonstrated, thus far, that we are able to deliver satisfactory results by paying attention to risk. This is achieved by 1) outperforming the market on its way down, and 2) matching or slightly underperforming the market on its way up. We wait for unforced errors and pick up the free lunches - maybe not free but for a dime or significantly less than its intrinsic value. - Did we dig for gems regardless of market's temperature? Check. We will never throw out the baby with the bath water under any conditions. Mastercard and Visa were bought at a valuation that is likely to produce mid-teens return for the medium term even though it reduces our kitty.
- Have we exercised patience, and analyze thoroughly before buying or selling ? Need to work on. We could have been better but we take it as a learning curve. Although we had done reasonably well for most of the stocks that we sold based on what we think it is worth, there is, however, one which we committed an elementary error – Anheuser Busch Inbev. It is not because we feel terrible that the stock has surged to over $79 (we sold at $64.6) but rather for the failure to do a proper analysis when we sold and then learnt later that we left significant value on the table. We do not feel terrible just because a stock surges from the price we sold. Two other stocks that we disposed have also gone up – Starhub (sold at S$3.28) and SIA Engineering (sold at S$3.87) – but these two are likely to be, at best, fully valued. We do not see how Starhub and SIAE earnings can grow at the same pace as how the stock prices suggest, particularly, Starhub because they have run out of tax assets and need to pay tax in cash very soon, but sure, they have better levers than the other telcos which they can pull to increase debt which may benefit shareholders.
We do not expect our current outperformance to
continue if the market gets more expensive by the day. In fact, if it gets
more expensive, we are likely to underperform, probably by a large margin.
Heaven knows how long the market's ascension can last, but one thing for
sure, nothing goes in one direction forever and on a straight path,
the day will come when something -expected or unexpected – that
will knock the breath out. In fact by being more conservative, we
have managed not to lose as much back for what we had laboriously
fought for. From end of April 2011 to end September 2011, the S&P500
lost 17% while our portfolio lost 10%. But we are not as conservative
at that time than we are now. The outcome as demonstrated by the most recent
smaller slump: From end of March 2012 to the 26 June 2012 (3 days
prior to the market surge that ends the first half on a high note),
S&P500 declined by 6.3% while our portfolio declines by 1.2%.
Thankfully,
we have managed to do reasonably well even when the market is not
particularly cheap and probably risky, while able to maintain a
reasonable cash level at 28% of assets, though down from 32% cash at
the start of year. The reduction in cash can be attributed to the
purchases for Mastercard and Visa.
What
are the main drivers for the portfolio first half performance?
- Coca Cola – We took the opportunity to add KO at an average price of about $67. We would not have added more Coca Cola had Pepsico price not been within 3 to 4% percentage less than KO because we do not think it is prudent to reduce cash holding significantly for a stock that is only slightly undervalued. But compared to Pepsico, KO is a better bet if KO is selling for only 3-4% more than PEP. Therefore, to fund the purchase, we reduced our then-significant exposure to Pepsico and bought into Coke. Although, we have since reduced roughly 2/5 of KO. Today, the difference between KO and PEP is about 10%, down from 15% earlier, in favor of KO. And let's not misinterpret this as a technical play or based just on the difference in prices. Rather, it is a comparison of which stock provides a better value if the price of Coke is 3-4% more than Pepsico. At $67 for KO, it is selling at almost the same multiples with PEP at $64-$65 and KO eps growth is brighter than PEP. This was prior to PEP's reduced earnings guidance. In total KO return 14.8% for the first half, and comprised about 13% of the total gain for the portfolio.
- Mastercard and Visa – Stakes were accumulated in January 2012. Return for the two shares is 17.6% since acquisition. This group comprised about 20% of portfolio total gain.
- United Overseas Bank – Up 25.5% for the first half. Makes up 24.4% of portfolio gain. However, the performance is much less stellar if measured from cost, up only 6.6% (although if measured in SGD terms, it is up 10%) since acquisition during second half of 2011.
- Berkshire Class B – Up about 9.2% for the first half. Comprised slightly over 9% of total gain. However, it is up by only 4.3% from cost. Shares were acquired at different times, with two-thirds acquired in May 2011, and the rest acquired in Jan 2011 and earlier.
- Haw Par – Up 17% year to date. Contributed 5% of total portfolio gain.
- Pepsico – Up 6.5% for the remaining shares. However for those shares that were sold, it was sold at a lower price ($65.74) than the price at the start of the year ($66.35), therefore, it lowered the gains for the remaining Pepsi shares.
- Remaining gains came from smaller positions such as DirecTV, Reckitt Benckiser, Becton Dickinson (partially sold), CSX (sold), Anheuser Busch Inbev (sold), Amgen (sold) and some opportunistic stocks like St. Jude Medical, Starhub, SIA Engineering and Baxter which are all sold.
- Opportunistic stocks – St. Jude Medical was acquired for $32.5 in December 2011 and was sold at a gain of 10.5% the next month. Baxter was similarly bought in December 2011 at $48.11 and sold two months later for a gain of over 16.8%. SIA Engineering was acquired in January 2012 for $3.38 and sold in March for a gain of 13.3%. Starhub was bought in January 2012 and sold recently in June 2012, for a gain of 20%. These four opportunistic stocks comprised about 7% of total portfolio gain.
- The above reflects the positions with positive returns. The total return for the above positions produced a gross gain of 9.7% year to date. But this is offset by some positions with losses Net result as shown along with Dow Jones Industrial Average as a comparison:
In
case you are wondering why we did not take S&P500 which is more
broad-base and representative as a comparison: DJIA only consists of
30 stocks and is a price-weighted index. This makes it easier to
calculate than to go through the hassle for S&P500.
- Losers for first half includes:
- Norfolk Southern (-1.4%),
- Western Union (-5.4%),
- Google (-3.6%),
- Celgene (-12%),
- Tesco PLC (-2.1%),
- Singapore Land (-1.8), and
- Molson Coors (-1.6%).
69% of the losses comes from Norfolk Southern, Pepsico (related to the shares sold to fund KO), and Celgene. Of the 3 main loss contributors, we hold a larger position in Norfolk and Pepsi compared to Celgene. Unfortunately, after purchasing at $73, it fell through the roof to a low of $59, and is now $64 and change,. This is mainly because of a delay to gaining new marketing approval for extended use in the E.U for its top selling drug . But at $59 or below, we stand ready to add because we think it has a strong line of current commercial drugs and also a decent pipeline that serves to extend use for existing drugs and also new drugs in trials.
*All
performance mentioned excludes dividend.
Additions
to portfolio:
- Mastercard and Visa
Started
accumulated in January 2012 with an initial allocation of 5.7% of
total assets. Subsequently, added another 4.2% of total assets in
May 2012 when there was a small correction for both stocks. In
total, almost 10% of total assets (based on start of year total
assets) were allocated in these two equities.
Average
price paid - $369 for Mastercard and $105 for Visa. Return since acquisition –
about 17.6% as a group.
Why
Mastercard and Visa? We paid about 16x on a forward 12 months earnings for
both. Medium growth rate for both stocks range from mid to high
teens for earnings per share. Any business with a fairly predictable
revenue stream, defensible business model, growth at well over 10%,
and available for 16x earnings is likely to do well. Historical eps
growth is well above 20% since their IPOs. Foreseeable medium
growth is over 15%.
Now take Mastercard as an example and assume growth slows to 10%, earnings by 2015 would then be $27.4 per share. In order to lose money, the stock must sell below 13.5x in 2015 and growth rate must slow to 10% for us to show a loss. Of course, if such a scenario happens, we will be extremely glad to double, triple or even quadruple our stake for a business that still carries a 10% growth rate and sells for a very reasonable 13.5x earnings.
Now take Mastercard as an example and assume growth slows to 10%, earnings by 2015 would then be $27.4 per share. In order to lose money, the stock must sell below 13.5x in 2015 and growth rate must slow to 10% for us to show a loss. Of course, if such a scenario happens, we will be extremely glad to double, triple or even quadruple our stake for a business that still carries a 10% growth rate and sells for a very reasonable 13.5x earnings.
Otherwise,
in a normal path, assuming an achievable medium per-share-earnings growth of
15%, by 2015, Mastercard would earn at least $40 per share on a
forward 12-months basis. Assuming there is no compression in
multiples from what we pay, at 16x, stock sells for $640, an annual
return of 15%. If multiples increase by 20% and sells for 19.2x,
stock will be worth $768, a return of 20% annually. Conversely, if
multiples compress by 20% (12.8x), stock will be worth $512, an
annual return of 8.5%. In which case at 12.8x multiples, we will
add a lot more, because we view the lagging stock price as if the
stock is brisk-walking at that moment before it picks up steam to
jog and then sprint and ultimately, the full value will be
recognized. So if the stock brisk-walks while the value is
increasing at a faster clip than the stock appreciation suggests, we
will be there to catch more of it.
In
fact, I am late to the game for Mastercard and Visa because I was sucking my thumb for too long and held my trigger at least twice in the
past, particularly, during December of 2010 when both of their
prices plunged due to the Durbin Amendment.
- DirecTV
Comprises
about 3% of total assets. We got familiarize with DTV when Berkshire
announced the hiring of Ted Weschler in mid 2011. We first bought
DTV in September 2011 at $40.99 and then dispose the next month at
$47.2. Then in December 2011, we bought again at $42. And in May
2012, we accumulated a bit more at $45. Average price is $43.4.
Why
did we buy and accumulate more even at a price higher than the
initial price? For one, it is cheap and cash flow is predictable.
The other factor is the stock price has not kept up with the value,
i.e., compression in price-to-earnings and it was pretty sizable
one. Management targets for over $5 eps in 2013. Therefore, at
$43.4, it is less than 9x multiples for a business with highly
predictable cash generating capability.
Return
year to date is 12.5%.
- IBM
Makes
up about 8.5% of total assets. Bought between the range of $178 to
$198, at an average of $188.6. IBM revenue is much more predictable
than what it used to be. IBM, in essence, is very different from the
start of the decade. The transformation, owning to Lou Gerstner, has
been focused on shifting the business to higher value areas of the
market, improving operating leverage and investing in opportunities
to drive growth. IBM operates in four major segments: 1) Global
Services (GS); 2) Software; 3) Systems and Technology (ST); and 4)
Global Financing. Out of the 4 segments, 3 have got annuity-like
characteristics.
“Global
Services” which makes up 56% of total revenue, 44% of pre-tax
income. Approximately 60% of GS revenue is annuity based, coming
primarily from outsourcing and maintenance arrangements.
Software
revenue is approximately two-third annuity based, the remaining 1/3
relates to one-time charge arrangements for charges like license
fees, subscription, etc. Software comprises about 24% of revenue and
47% of pre-tax income.
The
role of Global Financing is to facilitates client's acquisition of
IBM systems, software and services. It is similar to a finance
company except that it has the benefit of both a deep knowledge of
its client base and a clear insight into the products and services
that are being financed. This allows Global Financing to effectively
manage two of the major risks – credit and residue value – that
are normally associated with financing. This segment of business is
very annuity-like and held up well as demonstrated in the table
below.
Global
finance has done well even during the financial turmoil of 2008/9
and has grown strong since.
In
terms of valuation, we paid 14x for 2011 adjusted earnings and 12.6x
for 2012. Management has a detailed roadmap on steering the company
towards achieving goals for both the longer term and also medium.
IBM aims to earn $20 adjusted earnings per share in 2015. If IBM is
priced at 12x 2015 earnings which is cheaper than today and also on
a historical basis, it is worth $240, a return of 6.5% annually. If
it is priced at 14x 2015 earnings, it is worth $280, an annual
return of slightly over 10%. If it is priced at 16x 2015 earnings,
it is worth $320, an annual return of 14%. Of course, if the
earnings surprise on the upside, the return will likely be much
more. Conversely, it can as well surprise on the downside. But IBM
has been conservative in its guidance for a long time ever since
Gerstner's days.
- Norfolk Southern Railway
Norfolk
comprises about 4% of total assets. The stake arises from the sale
of CSX Rail, for which we divested at a net gain of 12.5% and bought
into NSC. However, there isn't much difference economically owning
either CSX or Norfolk unless the price-to-value margin between them
greatly diverge. I'm indifferent to either CSX or Norfolk on their
fundamental business. Both are likely to perform step in step of
each other because both possess almost the same economic
characteristics.
Average
purchase price for Norfolk is about $73, a loss of 1.4% since
purchase. I admit I should have been better in timing the purchases
because right after the purchase, it fell to as low as $64, had I
not gave in to my lack of patience. Having said that, railroads even
at $73 should provide a decent value, though it can be a little more
volatile and cyclical. But overtime, rails are in a good position to
earn more than today in the 5, 10 or 15 years from today. Though in
now to then, there will be aberrations, especially on volume, but
not so much on unit price. In fact, rails have demonstrated their
pricing power as can be seen in the below table for the major
railroads:
The tables clearly demonstrate the strength of all of the rail franchises on either side of the coasts through a full economic cycle. The pricing power held up well even in the face of market distortion in the years 2007 to 2009. Revenue per unit in 2009 is 7.7 to 10% more than 2007 for all the railroads even with unit volume falling 20% from 2007. Moreover, total volume in 2011 was still 10% less than its previous peak in 2006. Volume today is around the same as it is in 2003. One of the “concerns” on railroads, particularly the eastern railroads, was recently directed at the decline in coal volume which is likely to be secular rather than cyclical, as long as coal cannot compete with natural gas as a fuel for energy. Just this week, Rex Tillerson, CEO of Exxon Mobil, sort of admitted his mea culpa in going big into natural gas. However, the decline in the coal franchise (over 40% of total volume) is offset by growth in the overall merchandise businesses, particularly very strong growth in vehicle/car carloads with year to date volume growing in excess of 20%. In the latest weekly traffic report from the Association of American Railroads, the total coal carloads for year to date is down 10.8%, but the decline which started since 2011, is levering off. In the week of 25, coal volume is down only 0.4%. So any future decline in coal is bound to have a much lesser impact to total volume, and may even be accretive to volume if there's an untick. Although utilities are using less coal, coal is not going to go away totally, coal makes up 45% of electric energy sector in the U.S in 2011, down from 49% in 2007. According to an outlook released in January 2012 by EIA, coal is forecasted to generate 39% of all electricity generation over the next 25 years. Others are forecasting even lower - expecting coal to fall to 30% of all U.S electricity generation by 2020. Utilities are the major buyers of coal – buying more than 90% of coal mined in the U.S.
The tables clearly demonstrate the strength of all of the rail franchises on either side of the coasts through a full economic cycle. The pricing power held up well even in the face of market distortion in the years 2007 to 2009. Revenue per unit in 2009 is 7.7 to 10% more than 2007 for all the railroads even with unit volume falling 20% from 2007. Moreover, total volume in 2011 was still 10% less than its previous peak in 2006. Volume today is around the same as it is in 2003. One of the “concerns” on railroads, particularly the eastern railroads, was recently directed at the decline in coal volume which is likely to be secular rather than cyclical, as long as coal cannot compete with natural gas as a fuel for energy. Just this week, Rex Tillerson, CEO of Exxon Mobil, sort of admitted his mea culpa in going big into natural gas. However, the decline in the coal franchise (over 40% of total volume) is offset by growth in the overall merchandise businesses, particularly very strong growth in vehicle/car carloads with year to date volume growing in excess of 20%. In the latest weekly traffic report from the Association of American Railroads, the total coal carloads for year to date is down 10.8%, but the decline which started since 2011, is levering off. In the week of 25, coal volume is down only 0.4%. So any future decline in coal is bound to have a much lesser impact to total volume, and may even be accretive to volume if there's an untick. Although utilities are using less coal, coal is not going to go away totally, coal makes up 45% of electric energy sector in the U.S in 2011, down from 49% in 2007. According to an outlook released in January 2012 by EIA, coal is forecasted to generate 39% of all electricity generation over the next 25 years. Others are forecasting even lower - expecting coal to fall to 30% of all U.S electricity generation by 2020. Utilities are the major buyers of coal – buying more than 90% of coal mined in the U.S.
Rail
volume has not really had much of a tailwind behind its back yet. In
fact, housing and construction is still not far from the the bottom,
though it is off the bottom. When housing construction recovers, you
can be sure the rails will be a lot more busy. In the meantime,
rails still have the leverage to price their revenue to get them
through till volume fully recovers.
To
drive home the point of the strength of the rails, the revenue per
unit increased between 68 to 85% and operating income per unit is up
255% to 1320% for the period 2002 to 2011. Although CSX operating
income per unit increased by 1320%, it was driven by a tremendous
improvement in operating ratio, compared to the rest. Had CSX
started with operating ratio of 80-82%, like the rest, CSX operating
income per unit would have grown at about the same rate as the
others – in the 250-280% range.
Now,
let's do some valuation on Norfolk. Based on estimated per share
earnings of $5.87 for 2012, the price we paid at $73 gives a PE of
12.5x, not an unreasonable value. With patience, this stock is
likely to work out fine in the end. Will volume ever recover to its
previous peak? The question is when. In the meantime, we wait. And
while we wait, the railroads are increasing prices at a clip over
rail inflation. Just recently, CSX posted on its website to
increase export metallurgical coal tariff rates by 4%. But rising rates can be
a double-edged sword, so they cannot be too unreasonable because
rails are still regulated by the Surface Transportation Board which
has the authority to reduce charges deemed “unreasonable” as
railroad operators can only levy charges that cover their operating
costs and a rate of return on assets. And it is common that
customers has frequently voiced their opinions.
To
understand how railroads get to where they are today, we will
provide some color here. Before 1980, railroads were regulated for
93 years and unable to set prices. With the advent of vehicles and
better connectivity of highway, competition was heightened for the
railroads. While railroads were regulated, truckers and waterways
operators were unregulated, and thus operated on a free market basis
which was a huge disadvantage for the railroads. By the 1970s,
railroads was on the brink of collapse. Bankruptcies were common,
earnings were too low to maintain tracks and equipments in good
condition,, and operating costs were rising. As a result, rails
infrastructure were in shambles and service level was atrocious. At
that time, nationalization was even considered. Eventually, it led
to the Staggers Act of 1980 which deregulated the industry.
Importantly, this act allows railroads to set prices that gives them
a chance to compete with truck and barge operators. Consequently,
railroads turned the table and were able to churn out profits that
would motivate them to reinvest in the business. This led to a
cumulative reinvestment of $480 billion since 1980. Today, railroads
infrastructure is healthy and service level is up year to year. This
has not only allowed railroads to prosper but have also contributed
greatly to the advance of the U.S economy. The railroad are
essentially the backbone for facilitating faster and more efficient
movement of goods, provided the proper infrastructure are in place
and are serviceable with a reliable service schedule and level. So
to re-regulate the rail industry would take a brave-heart to do so
unless the industry trips over themselves.
- Celgene
A
very small position bought for 15.5x adjusted 2012 earnings at $73.
Growth rate of 10-15%. Celgene is a biopharmaceutical with a few
commercial drugs manufactured and marketed by them. The main revenue
driver is Revlimid, a drug used for a type of blood cancer, Multiple
Myeloma(MM). In treating MM, there're basically three drugs, 2 of
which belongs to Celgene and the other, a subsidiary of Johnson and Johnson. Revlimid, along with the one by JNJ, are the two first-line
drugs used in treating MM. The other drug that has the potential to
attain blockbuster status in Celgene's fold is Abraxane, currently
only approved as a second-line treatment for metastatic breast
cancer. But there are a number of clinical trials (from early to
late stage) to study extended use of Abraxane in other areas of
oncology, for example, pancreatic. Celgene is hopeful Abraxane will
eventually be a major driver of revenue. However, I made a decision
buying Celgene in a haste. I would be better off had I exercise
patience again. But I still think Celgene provides a good likelihood
that I will be proven right because their existing commercial drugs
are running strong, and the pipeline should also provide some boost
in the future. And perhaps as a form of self-consolation, Celgene's
management is still targeting at least $8 adjusted earnings per
share in 2015. We shall see.
- Singapore and other stocks – M1, Singapore Land and Tesco (small positions)
- Bought M1 at S$2.42 early in the year. Received S$0.079 in the meanwhile as dividend and stock ended June 2012 at $2.56. M1 was bought along with Starhub at the same time, but Starhub has been sold in June 2012 at S$3.28, which appreciated from S$2.72.
- Singapore Land was bought at S$5.65 in Feb 2012 . Highly discounted from book value. Sells for a reasonable 10x cash flow. A majority amount of predictable revenue such as rental and hotel operations which can cushion the impact of the cyclical property development business. Excluding property development income, the predictable segments earns about S$0.50 to S$0.54, about 10.5 to 11x earnings multiple.
- Tesco is the giant UK retailer with international operations in Thailand, Malaysia and other parts of Asia and Europe. Bought Tesco in Jan 2012 at-the-then-3-or-5-year-lows at £3.155 per share or about 9x expected earnings. While we wait for the management to turn the UK retail business around, we get paid over 4% in dividend. Surely, a turnaround in retail is never a sure-thing. Just look at Carrefour, they even cut dividend. But in Tesco, we shall see. I believe fundamentally, they are not as bad as Carrefour. There's a reasonable chance for them. And that's why this is not a huge bet but a small one.
While
on the topic of a huge bet in a single or couple of positions, I have
not had one since late 2008 and early 2009. The last stock with more
than 20% in one position was Pepsico during 2011 but has since been
watered down to get into more favorable positions. Pepsico was
acquired for stability rather than an outright bet on a huge gain.
Now our largest position is in cash.
In
total, we hold 19 different equities – a record number we have ever
held at single time. Our top five positions of equities make up 54%
of all equities value (excluding cash). Our top seven positions
comprise 65% of all equities ex cash. Our seven largest positions are
Berkshire Hathaway, IBM, UOB, Mastercard, Pepsico, Coca Cola, and
Norfolk Southern, in the order of size. None of the positions account
for more than 10% of total assets including cash. However, three of
the positions accounts for more than 10% of equities value when cash
are excluded.
Compared
to where we started off, we had only 5 positions, with the top 2
positions making up 84% of all assets. Today is unlike the days when
we started off where bargains were abound. Some were selling for as
cheap as 20 cents on the dollar - for example, you can buy American
Express at $10 and now $57. If you dig a little more, there were even
10 cents on the dollar - for example, Liberty Interactive which was
available at $2 and now almost $18. The top 2 positions held then
were Wells Fargo and American Express. None of which we hold today.
When the market is in turmoil, it is easier to just concentrate your
positions in a couple of stocks because you don't need to worry on
risk as much as now.
Lastly,
divestures include Anheuser-Busch Inbev, Baxter, St. Jude Medical,
Starhub, CSX Railway, Molson Coors, Amgen, and SIA Engineering. We
only lost money on Molson Coors – a lost of 4.6% from what we pay,
but partially offset by dividends.
Mea-Culpa
Confession X 2
Deja
vu, this one is so reminiscent of what I did to Davita in the last
quarter of 2011. Of all the divestures for 2012, the only one I think
I made a mistake is Anheuser-Busch Inbev because it is a well-managed business with a first class CEO alongside a set of first-class
owners. It is a business that is focused on operational excellence and
provides a good growth rate (at least a high single digit growth). I
wish I know what I was thinking of when we sold BUD.
I
sold BUD at $64.6 early 2012 and regretted almost immediately when I
analyze in details. After that, it surges up. Then I bide for my
time. The stock hit a high of $74 over a month or so and then
gradually decline, and fell to slightly below $67. This is when I
committed a second mistake. Because I sold at $64.6, it became a drag
and anchor to buy again even though at $67, it was selling for 14.5x
2012 earnings, and much less for next. At this valuation, it will
likely provides a decent return. I told myself to buy at $67 but when
it fell below that, I kept thinking about $64.6. Only heaven knows
what I am thinking about. Now, the stock is even further from my
reach – last done at over $79. But well, I do not have to think
about them since the potential upside is pretty much lesser now and
not worth the risk to pursue.
You
can bet this will likely happen again because BUD case is not the
first time it happens. In fact, it is reminiscent to what I did for
Davita late last year. Davita was acquired for $63 in September 2011
and sold for $74 soon. Again, it was a mistake for failure to think
before selling. Then the stock only went up to a point of $90. Then I
bided for time hoping to repurchase again at a better price. About
two months ago, DVA announced a deal to acquired Healthcare Partners
which will be slightly accretive to earnings and purchase for a
reasonable price. The market did not react well to the news and price
fell to $78. At $78, it was selling at about the same multiple as
what I paid for in 2011. But I got anchored by the price I sold
earlier. Unfortunately, the price never came back down to $74. Now it
is over $95, way beyond my reach. Two deals which I clearly made the
same type of mistakes eerily follow a similar path in consequence.
What have I found out? Tying and anchoring yourself to the past and
basing a decision on other than facts is detrimental to one's
financial well-being which I have learnt but hopefully, will
practice.
Finally,
to close the letter, I recommend reading the book – Dethroning the
King: The Hostile Takeover of Anheuser-Busch.
NOTE: All currencies are in USD unless otherwise indicated. Returns are all measured in USD.
Subscribe to:
Posts (Atom)












